Eyewire News

Featured Story

Ocugen Doses First Patient in Global Phase 3 Trial of OCU410 for Geographic Atrophy image

09.01.2026

Ocugen Doses First Patient in Global Phase 3 Trial of OCU410 for Geographic Atrophy

Ocugen has dosed the first patient in a global phase 3 registrational trial evaluating OCU410, an investigational modifier gene therapy for geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). The milestone follows the FDA’s July 29, 2026, regenerative medicine advanced therapy (RMAT) designation for OCU410 and completion of a Type B end-of-phase 2 meeting with the agency’s Center for Biologics Evaluation and Research (CBER).

Read Story

Latest News Stories

Samsara Vision Names Jason Herod President and CEO image

09.01.2026

Samsara Vision Names Jason Herod President and CEO

09.01.2026

Bausch + Lomb Survey Finds Low Awareness of Dry Eye as a Menopause-Related Symptom

Medicel to Launch Bicel Soft Tip I/A Terralution for Bimanual Irrigation and Aspiration image

09.01.2026

Medicel to Launch Bicel Soft Tip I/A Terralution for Bimanual Irrigation and Aspiration

Rayner’s Innoptix Division Reports 5,000 Patients Enrolled on Eyejourney Platform Internationally image

09.01.2026

Rayner’s Innoptix Division Reports 5,000 Patients Enrolled on Eyejourney Platform Internationally

X-Cel and Essilor Launch Lunara Overnight Orthokeratology Lens image

08.31.2026

X-Cel and Essilor Launch Lunara Overnight Orthokeratology Lens

Kiora Licenses South Korean Rights to KIO-301 for RP to Chong Kun Dang image

08.31.2026

Kiora Licenses South Korean Rights to KIO-301 for RP to Chong Kun Dang

08.31.2026

Antibiotic Injection Associated with Lower Endophthalmitis Risk After Cataract Surgery, Meta-Analysis Finds

08.31.2026

Stem Cell-Derived Retina Model Identifies RPE Dysfunction as Early Driver of Vision Loss in CLN3-Batten Disease

08.28.2026

Cataract Surgery Outcomes Poorer in Outreach Camps Than Fixed Facilities, Global Study Finds

08.28.2026

UK Government Outlines Measures to Reduce Ophthalmology Waiting Times

08.27.2026

California Bill Targeting Gaps in Children's Medi-Cal Vision Care Heads to Governor

Zeiss to Launch Cataract-Only Configuration of DORC EVA Nexus Surgical System at ESCRS image

08.27.2026

Zeiss to Launch Cataract-Only Configuration of DORC EVA Nexus Surgical System at ESCRS

08.27.2026

FDA Accepts Nicox's NDA for NCX 470 for Glaucoma and Ocular Hypertension

FDA Grants Authorization to Avulux Precision Light-Filtering Lenses for Migraines image

08.27.2026

FDA Grants Authorization to Avulux Precision Light-Filtering Lenses for Migraines

Sightview Launches Updated Ophthalmology EHR and Practice Management Platform image

08.26.2026

Sightview Launches Updated Ophthalmology EHR and Practice Management Platform

08.25.2026

TECLens Closes $10 Million Series A2 Financing to Advance Noninvasive Refractive Vision Correction Internationally

Bausch + Lomb Advances Dry Eye Combination and BL1332 Ocular Pain Programs image

08.25.2026

Bausch + Lomb Provides Updates on Dry Eye Combination and BL1332 Ocular Pain Programs

08.24.2026

Oculis Doses First Patient in Phase 3 PIONEER-1 Trial of Privosegtor for Optic Neuritis

SightGlass Vision Reports 2 Million Children Worldwide Have Worn Dot Spectacle Lenses image

08.24.2026

SightGlass Vision Reports 2 Million Children Worldwide Have Worn Dot Spectacle Lenses

View More